Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).

dc.contributorSisätautioppi-
dc.contributor.authorGrönberg, Toni
dc.contributor.departmentfi=Kliininen laitos|en=Institute of Clinical Medicine|
dc.contributor.facultyfi=Lääketieteellinen tiedekunta|en=Faculty of Medicine|
dc.contributor.studysubjectfi=Sisätautioppi|en=Internal Medicine|
dc.date.accessioned2016-04-07T10:06:09Z
dc.date.available2016-04-07T10:06:09Z
dc.date.issued2016-04-07
dc.description.notificationSiirretty Doriasta
dc.format.contentabstractOnly
dc.identifier.olddbid137005
dc.identifier.oldhandle10024/122001
dc.identifier.urihttps://www.utupub.fi/handle/11111/5655
dc.language.isofin-
dc.publisherfi=Turun yliopisto|en=University of Turku|
dc.source.identifierhttps://www.utupub.fi/handle/10024/122001
dc.titleAnticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).-
dc.type.ontasotfi=Syventävien opintojen kirjallinen työ|en=Second Cycle degree thesis|

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
GrönbergToni.pdf
Size:
71.91 KB
Format:
Adobe Portable Document Format
Description:
Tiivistelmä